Most adults in the United States with physical chronic health conditions manage them at work but have not told their employer ...

Paxlovid may not decrease the risk for hospitalization or death in older adults vaccinated against COVID-19 as much as ...

The FDA has approved Ctexli for the treatment of cerebrotendinous xanthomatosis (CTX), a rare lipid storage disease, in ...

Published results showed patients with obesity who took anti-obesity medications and had postoperative weight loss within 1 year after total joint arthroplasty may be at significantly decreased risk ...

Adolescents in the United States with symptoms of ADHD had a higher likelihood of using tobacco and other nicotine-based ...

As we approach the first anniversary of omalizumab’s approval for food allergy, its use is “definitely going to grow,” Robert ...

The investigational new drug application for Zabalafin Hydrogel for the treatment of mild to moderate atopic dermatitis has ...

Virtual reality headsets for visual field testing in glaucoma offer a variety of benefits for the patient, the practice and ...

The American Heart Association and American College of Cardiology issued a scientific statement detailing clinical guidance ...

The FDA has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can ...

The presentation of Cushing’s disease varies by age, with older adults having fewer hallmark features of the condition and ...

The latest data from The Vision Council’s Market inSights report indicate that the proportion of contact lenses and glasses ...